Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
J Ren Nutr. 2010 May;20(3):158-68. doi: 10.1053/j.jrn.2009.10.008. Epub 2010 Jan 25.
The increase of reactive oxygen species (ROS) in diabetes potentiates the vascular effects of phenylephrine through nitric oxide (NO) impairment, facilitating the development of diabetic nephropathy. We propose that the combination of an antioxidant and L-arginine as diet supplements could prevent the increased vascular response to phenylephrine in diabetic animals.
Changes in the adrenergic system play an important role in the development of vascular complications in the prediabetic condition. The vasoconstrictor effects of phenylephrine are regulated by NO, and the impairment of endothelium-dependent vasodilation in diabetes is associated with ROS.
Diabetes was induced with a low dose (55 mg/kg body weight) of streptozotocin in 7-week-old rats. Diabetic rats were fed with a diet supplement containing a combination of vitamin E, vitamin C, eicosapentaenoic acid, docosahexaenoic acid, and L-arginine, and the effects on phenylephrine-induced renal vascular responses were evaluated.
Phenylephrine increased the renal perfusion pressure of isolated perfused kidneys from diabetic rats compared with nondiabetic rats. This effect was associated with reduced nitrite release as well as reduced plasma tetrahydrobiopterin and increased superoxide anions in the renal tissue. Diet supplementation with a combination of L-arginine and vitamins in diabetic rats partially prevented the generation of superoxide associated with recovery of the renal release of NO and decreased phenylephrine-induced vasoconstrictor effects, compared with untreated diabetic rats. However, the administration of L-arginine or vitamins alone did not affect phenylephrine-induced vasoconstriction. Vitamin treatment alone did decrease superoxide generation.
The protective mechanism of NO on the vasoconstrictor effects of phenylephrine in the kidney is lost during the development of diabetes, probably via the actions of ROS through a decrease in tetrahydrobiopterin, thus contributing to the pathogenesis of diabetic nephropathy. Restoration of this protective NO mechanism can be achieved by simultaneously stimulating NO synthesis and preventing the effects of ROS through the use of L-arginine and a combination of vitamins E and C as diet supplementation.
糖尿病患者体内活性氧(ROS)的增加会通过损害一氧化氮(NO)使去甲肾上腺素的血管效应增强,从而促进糖尿病肾病的发生。我们提出,抗氧化剂和左旋精氨酸的联合作为饮食补充剂可能会防止糖尿病动物对去甲肾上腺素的血管反应增加。
儿茶酚胺系统的变化在糖尿病前期状态下血管并发症的发展中起着重要作用。去甲肾上腺素的血管收缩作用受 NO 调节,而糖尿病中内皮依赖性血管舒张功能的损害与 ROS 有关。
在 7 周龄大鼠中用低剂量(55mg/kg 体重)链脲佐菌素诱导糖尿病。糖尿病大鼠用含有维生素 E、维生素 C、二十碳五烯酸、二十二碳六烯酸和左旋精氨酸的饮食补充剂喂养,并评估其对去甲肾上腺素诱导的肾血管反应的影响。
与非糖尿病大鼠相比,去甲肾上腺素增加了糖尿病大鼠离体灌注肾脏的肾灌注压。这种作用与肾组织中硝酸盐释放减少、血浆四氢生物蝶呤减少以及超氧阴离子增加有关。与未治疗的糖尿病大鼠相比,糖尿病大鼠饮食补充左旋精氨酸和维生素可部分预防与肾 NO 释放恢复相关的超氧阴离子的产生,并降低去甲肾上腺素引起的血管收缩作用,但单独给予左旋精氨酸或维生素对去甲肾上腺素引起的血管收缩没有影响。单独的维生素治疗可减少超氧阴离子的产生。
在糖尿病的发展过程中,NO 对肾去甲肾上腺素血管收缩作用的保护机制丧失,可能是通过降低四氢生物蝶呤来发挥 ROS 的作用,从而导致糖尿病肾病的发病机制。通过同时刺激 NO 合成并通过使用左旋精氨酸和维生素 E 和 C 的混合物作为饮食补充来防止 ROS 的作用,可以恢复这种保护的 NO 机制。